Profitability
This table compares TransEnterix and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| TransEnterix | -2,149.15% | -83.74% | -64.94% |
| TransEnterix Competitors | -672.41% | -133.75% | -59.01% |
Institutional & Insider Ownership
8.2% of TransEnterix shares are held by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 3.1% of TransEnterix shares are held by company insiders. Comparatively, 18.1% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares TransEnterix and its peers top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| TransEnterix | $8.53 million | -$154.20 million | -0.04 |
| TransEnterix Competitors | $59.54 million | -$32.15 million | 4.35 |
Volatility and Risk
TransEnterix has a beta of 2.56, indicating that its stock price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s peers have a beta of 1.76, indicating that their average stock price is 76% more volatile than the S&P 500.
Summary
TransEnterix peers beat TransEnterix on 7 of the 9 factors compared.
TransEnterix Company Profile
TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.
Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.
